View More View Less
  • 1 Slovak Academy of Sciences Institute of Animal Physiology Košice Slovakia
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

In children, acute otitis media (AOM) is one of the most frequently occurring infections caused by Streptococcus pneumoniae and Str. pyogenes. The standard treatment of AOMis provided by antibiotics; however, an increased resistance of the causative agents to antibiotics requires the need to search for innovations. This study was focused on in vitro testing sensitivity of streptococci isolated from AOM to enterocins produced by 9 different origin strains of E. faecium. Enterocins (Ent) represent ribosomally synthesized proteinaceous substances with antimicrobial activity against Gram-positive and/or Gram-negative bacteria which are produced mostly by strains of the species Enterococcus faecium. Str. pneumoniae were sensitive at least to 1 Ent. Str. pneumoniae SPn 754 was sensitive to 5 Ent. Five Str. pyogenes were sensitive to enterocins. Ent A (P) inhibited the growth of 3 Str. pneumoniae, and 4 Str. pyogenes (activity between 100 and 3,200 AU/ml). Most of Ent inhibited the growth of streptococci tested (100–3,200 AU/ml). Str. pyogenes were more sensitive to Ent than Str. pneumoniae. Although more detailed further studies are required, our results indicate a new possibility for enterocin use.

  • Kayser, F. H., Bienz, K. A., Eckert, J., Zinkernagel, R. M.: Medical Microbiology. Thieme, Stuttgart, New York, 2005.

    Zinkernagel R. M. , '', in Medical Microbiology , (2005 ) -.

  • Klein, J. O.: The burden of otitis media. Vaccine 19(Suppl), S2–S8 (2001).

    Klein J. O. , 'The burden of otitis media ' (2001 ) 19 Vaccine : S2 -S8.

  • Garcia-Rodrigues, J. A., Martinéz, M. J. F.: Dynamics of nasopharyngeal colonization by potential respiratory pathogens. J. Antimicrob. Chemother. 50(Suppl S2), 59–73 (2002).

    Martinéz M. J. F. , 'Dynamics of nasopharyngeal colonization by potential respiratory pathogens ' (2002 ) 50 J. Antimicrob. Chemother. : 59 -73.

    • Search Google Scholar
  • Fischetti, V. A.: Streptococcal Mprotein: Molecular design and biological behaviour. Clin. Microbiol. Rev. 2, 285–314 (1989).

    Fischetti V. A. , 'Streptococcal Mprotein: Molecular design and biological behaviour ' (1989 ) 2 Clin. Microbiol. Rev. : 285 -314.

    • Search Google Scholar
  • Kehoe, M. A.: Cell-wall associated proteins in Gram positive bacteria. N. Compr. Biochem. 27, 217–223 (1994).

    Kehoe M. A. , 'Cell-wall associated proteins in Gram positive bacteria ' (1994 ) 27 N. Compr. Biochem. : 217 -223.

    • Search Google Scholar
  • Franz, C. M. A. P., van Belkum, M. J., Holzapfel, W. H., Abriouel, H., Gálvéz, A.: Diversity of enterococcal bacteriocins and their grouping in a new classification scheme. FEMS Microbiol. Rev. 31, 293–310 (2007).

    Gálvéz A. , 'Diversity of enterococcal bacteriocins and their grouping in a new classification scheme ' (2007 ) 31 FEMS Microbiol. Rev. : 293 -310.

    • Search Google Scholar
  • Lauková, A., Czikková, S.: Inhibition effect of enterocin CCM4231 in the rumen fluid environment. Lett. Appl. Microbiol. 26, 215–218 (1998).

    Czikková S. , 'Inhibition effect of enterocin CCM4231 in the rumen fluid environment ' (1998 ) 26 Lett. Appl. Microbiol. : 215 -218.

    • Search Google Scholar
  • Lauková, A., Czikková, S., Vasilková, Z., Juriš, P., Krupicer, I.: Antimicrobial effect of enterocin CCM 4231 in the cattle slurry environment. Cytobios 94, 73–79 (1998).

    Krupicer I. , 'Antimicrobial effect of enterocin CCM 4231 in the cattle slurry environment ' (1998 ) 94 Cytobios : 73 -79.

    • Search Google Scholar
  • Lauková, A., Turek, P., Mareková, M., Nagy, J.: Use of ent M, new variant of ent P to control Listeria innocua in experimentally contaminated Gombasek sausage. Arch. Lebensmittel. 54, 46–48 (2003).

    Nagy J. , 'Use of ent M, new variant of ent P to control Listeria innocua in experimentally contaminated Gombasek sausage ' (2003 ) 54 Arch. Lebensmittel. : 46 -48.

    • Search Google Scholar
  • Lauková, A., Guba, P., Nemcová, R., Mareková, M.: Inhibition of Salmonella enterica serovar Duesseldorf in gnotobiotic Japanese quails. Vet. Med. Czech. 49, 47–51 (2004).

    Mareková M. , 'Inhibition of Salmonella enterica serovar Duesseldorf in gnotobiotic Japanese quails ' (2004 ) 49 Vet. Med. Czech. : 47 -51.

    • Search Google Scholar
  • Pogány Simonová, M., Lauková, A., Chrastinová, L’., Strompfová, V., Faix, Š., Vasilková, Z., Ondruška,L’., Jurcík, R., Rafay, J.: Enterococcus faecium CCM 7420, bacteriocin PPB CCM 7420 and their effect in the digestive tract of rabbits. Czech J. Anim. Sci. 54, 376–386 (2009).

    Rafay J. , 'Enterococcus faecium CCM 7420, bacteriocin PPB CCM 7420 and their effect in the digestive tract of rabbits ' (2009 ) 54 Czech J. Anim. Sci. : 376 -386.

    • Search Google Scholar
  • Levkut, M., Revajová, V., Lauková, A., Ševcíková, Z., Spišáková, V., Faixová, Z., Levkutová, M., Strompfová, V., Pistl, J., Levkut, M.: Leucocytic responses and intestinal mucin dynamics of broilers protected with Enterococcus faecium EF55 and challenged with Salmonella enteritidis. Res. Vet. Sci. (2011) doi:10.1016/j.rvsc.2011.06.021.

  • Aymerich, T., Holo, H., Havarstein, L. S., Hugas, M., Garriga, M., Nes, I. F.: Biochemical and genetic characterization of enterocin A from Enterococcus faecium, a new antilisterial bacteriocin in the pediocin family of bacteriocins. Appl. Environ. Microbiol. 62, 1676–1682 (1996).

    Nes I. F. , 'Biochemical and genetic characterization of enterocin A from Enterococcus faecium, a new antilisterial bacteriocin in the pediocin family of bacteriocins ' (1996 ) 62 Appl. Environ. Microbiol. : 1676 -1682.

    • Search Google Scholar
  • Mareková, M., Lauková, A., De Vuyst, L., Skaugen, M., Nes, I. F.: Partial characterization of bacteriocins produced by environmental strain Enterococcus faecium EK13. J. Appl. Microbiol. 94, 523–530 (2003).

    Nes I. F. , 'Partial characterization of bacteriocins produced by environmental strain Enterococcus faecium EK13 ' (2003 ) 94 J. Appl. Microbiol. : 523 -530.

    • Search Google Scholar
  • Mareková, M., Lauková, A., Skaugen, M., Nes, I. F.: Isolation and characterization of a new bacteriocin, termed enterocin M produced by environmental isolate Enterococcus faecium AL41. J. Ind. Microbiol. Biotechnol. 34, 533–537 (2007).

    Nes I. F. , 'Isolation and characterization of a new bacteriocin, termed enterocin M produced by environmental isolate Enterococcus faecium AL41 ' (2007 ) 34 J. Ind. Microbiol. Biotechnol. : 533 -537.

    • Search Google Scholar
  • De Vuyst, L., Callewaert, R., Pot, B.: Characterization of antagonistic activity of Lactobacillus amylovorus DCE471 and large-scale isolation of its bacteriocin amylovorin L471. Syst. Appl. Microbiol. 19, 9–20 (1996).

    Pot B. , 'Characterization of antagonistic activity of Lactobacillus amylovorus DCE471 and large-scale isolation of its bacteriocin amylovorin L471 ' (1996 ) 19 Syst. Appl. Microbiol. : 9 -20.

    • Search Google Scholar
  • Howell, T. H., Fiorellini, J. P. Blackburn, P., Projan, S. J., de la Harpe, J., Williams, R. C.: Effect of a mouthrinse based on nisin, a bacteriocin on developing plaque and gingivitis in beagle dogs. J. Clin. Periodont. 20, 335–339 (1993).

    Williams R. C. , 'Effect of a mouthrinse based on nisin, a bacteriocin on developing plaque and gingivitis in beagle dogs ' (1993 ) 20 J. Clin. Periodont. : 335 -339.

    • Search Google Scholar
  • Blackburn, P., Projan, S. J.: Pharmaceutical bacteriocin combinations and methods for using the same. United Patent No. 5 304 540. Appl. Microbiol. Inc., New York, USA (1994).

    Projan S. J. , '', in Pharmaceutical bacteriocin combinations and methods for using the same , (1994 ) -.

  • Hill, R. P., Farkas-Himsley, H.: Further studies of the action of a partially purified bacteriocin against a murine fibrosarcoma. Can. Res. 51, 1359–1365 (1991).

    Farkas-Himsley H. , 'Further studies of the action of a partially purified bacteriocin against a murine fibrosarcoma ' (1991 ) 51 Can. Res. : 1359 -1365.

    • Search Google Scholar
  • Kellner, R., Jung, G., Horner, T., Zähner, H., Schnell, N., Entian, K. D., Gotz, F.: Gallidermin, a new lanthionine containing polypeptide antibiotic. Eur. J. Biochem. 177, 53–59 (1988).

    Gotz F. , 'Gallidermin, a new lanthionine containing polypeptide antibiotic ' (1988 ) 177 Eur. J. Biochem. : 53 -59.

    • Search Google Scholar
  • Lauková, A., Pogány Simonová, M., Plachá, I., Strompfová, V., Cobanová, K., Szabóová, R., Chrastinová, L’.: Comparing the effect of probiotic enterococci and their enterocins in rabbits in relation to microbiological status and phagocytic activity. In Levkut et al. (eds): Intestinal Barrier of Animals and Alternative Methods of their Influence. Košice, Slovakia, 2009, pp. 22–25.

    Chrastinová L.’. , '', in Intestinal Barrier of Animals and Alternative Methods of their Influence , (2009 ) -.

  • Dluholucký, S., Frcová, B., Králinská, I., Purgel’ová, A.: Characteristics of otitis media acuta requesting hospitalization of children. Pediatry and Practise 1, 40–43 (2008).

    Purgel’ová A. , 'Characteristics of otitis media acuta requesting hospitalization of children ' (2008 ) 1 Pediatry and Practise : 40 -43.

    • Search Google Scholar
  • Pogány Simonová, M., Lauková, A., Haviarová, M.: Pseudomonads from rabbits and their sensitivity to antibiotics and natural antimicrobials. Res. Vet. Sci. 88, 203–207 (2010).

    Haviarová M. , 'Pseudomonads from rabbits and their sensitivity to antibiotics and natural antimicrobials ' (2010 ) 88 Res. Vet. Sci. : 203 -207.

    • Search Google Scholar
  • Lauková, A., Šedová, D.: Sensitivity of Pseudomonas sp. from environmental sources to antibiotics and enterocins. Program and Abstracts from 25. Congress of Czech-Slovak Society of Microbiology, 15–18. 9. 2010, Stará Lesná, p. 220. ISBN970-80-970477-8-8.

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Online subsscription: 652 EUR / 812 USD
Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Feb 2021 5 0 0
Mar 2021 6 0 0
Apr 2021 1 0 0
May 2021 1 0 0
Jun 2021 8 0 0
Jul 2021 1 0 0
Aug 2021 0 0 0